Comparison

LY-3475070 European Partner

Item no. TMO-T8875-5mg
Manufacturer TargetMol
CASRN 2375815-63-5
Amount 5mg
Category
Type Inhibitors
Specific against other
Purity 99.59%
Smiles CC1=NN=C(C=C1[C@H]2C[C@@H]2C(C)C)C3=CNC(=O)NC3=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 2375815-63-5, LY-3475070 , EX-A4254
Available
Short Description
LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.
Shipping
cool pack
Storage
-20°
Target names or alias
LY-3475070 , EX-A4254
Molecular Weight
286, 33
Pathway
Immunology/Inflammation
Target
CD73

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Delivery expected until 8/30/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close